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Abstract 
Differentiation of human endometrial stromal cells (HESCs) into decidual cells 
represents a highly coordinated process essential for embryo implantation. We show 
that decidualizing HESCs downregulate the histone methyltransferase enhancer of 
Zeste homologe 2 (EZH2), resulting in declining levels of trimethylated lysine 27 of 
histone 3 (H3K27me3) at the proximal promoters of key decidual marker genes, PRL 
and IGFBP1.  Loss of H3K27me3 was associated with a reciprocal enrichment in 
acetylation of the same lysine residue, indicating active remodeling from repressive to 
transcriptionally permissive chromatin. Chromatin immunoprecipitation coupled with 
DNA microarray demonstrated that decidualization triggers genome-wide changes in 
H3K27me3 that only partly overlap those observed upon EZH2 knockdown in 
undifferentiated HESCs. However, gene ontology analyses revealed that gain and loss 
of the repressive H3K27me3 mark upon differentiation as well as EZH2 knockdown 
occurred at loci enriched for genes functionally implicated in cell proliferation and 
responses to stimulus, respectively. In agreement, EZH2 knockdown in 
undifferentiated HESCS was sufficient to augment the induction of decidual marker 
genes in response to cyclic AMP and progesterone signaling. Thus, loss of EZH2-
dependent methyltransferase activity in the endometrium is integral to the process of 
chromatin remodeling that enables acquisition of a decidual phenotype in response to 
differentiation cues. 
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Differentiation of human endometrial stromal cells (HESCs) into decidual cells 
represents a highly coordinated process essential for embryo implantation. Here we 
show that decidualization during the mid-secretory phase of the cycle coincides with a 
profound downregulation of enhancer of Zeste homolog 2 (EZH2), the enzymatic 
subunit of the repressive Polycomb complex 2 that trimethylates lysine 27 of histone 
3 (H3K27me3). EZH2 was also profoundly downregulated upon differentiation of 
primary HESCs, which coincided with a gradual loss of the H3K27me3 mark at the 
proximal promoters of key decidual marker genes, PRL and IGFBP1. Loss of 
H3K27me3 at these loci was further associated with a reciprocal enrichment in 
acetylation of the same lysine residue (H3K27ac), indicating active remodeling from 
repressive to transcriptionally permissive chromatin. EZH2 knockdown in 
undifferentiated HESCS reduced the abundance of H3K27me3 at the proximal PRL 
and IGFBP1 promoters and augmented the induction of these marker genes in 
response to cyclic AMP and progesterone signaling. Chromatin immunoprecipitation 
coupled with DNA microarray demonstrated that decidualization triggers genome-
wide changes in H3K27 methylation that are largely distinct from those observed 
upon EZH2 knockdown in undifferentiated HESCs. However, gene ontology analyses 
revealed that gain and loss of the repressive H3K27 mark under both experimental 
conditions occurred at loci functionally enriched for genes implicated in cell 
proliferation and responses to stimulus, respectively. Thus, loss of EZH2-dependent 
methyltransferase activity in the endometrium is integral to the process of chromatin 
remodeling that enables acquisition of a decidual phenotype in response to 
differentiation cues.  
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Introduction 
The postovulatory rise in progesterone levels drives the differentiation of the 
endometrium in preparation of pregnancy, a highly coordinated and sequential 
process characterized by secretory transformation of the glandular epithelium, influx 
of specialized immune cells, decidualization of the stroma, and vascular remodeling 
(1-3). Although progesterone signaling is indispensible, the sequential nature of this 
differentiation process is thought to reflect the actions of locally produced cytokines 
and growth factors. For example, decidualization, which denotes the differentiation of 
endometrial stromal cells into epitheloid decidual cells, is a classical progesterone-
dependent process, although this process is initiated in vivo only approximately 9 days 
after the ovulatory surge in circulating progesterone levels (4-6). Similarly, purified 
human endometrial stromal cells (HESCs) in culture are also largely refractory to 
progesterone signaling, despite abundantly expressing the nuclear progesterone 
receptors PR-A and –B (4,7,8). However, progesterone does acquire control over the 
expression of decidual markers genes, such as PRL and IGFBP-1, upon simultaneous 
activation of the cAMP pathway (4,9-11). Endometrial cAMP levels also increase in 
vivo during the luteal phase, probably reflecting the induction of local factors that 
activate adenylate cyclase in stromal cells, such as relaxin, corticotropin-releasing 
hormone, and prostaglandin E2 (5). 
Multiple mechanisms have been shown to underpin the convergence of the 
cAMP and progesterone signal pathways in HESCs. For example, cAMP inhibits 
ligand-dependent sumoylation of PR (11,12), a posttranslational modification that 
limits the transactivation capacity of this nuclear receptor (13). Increased cAMP 
levels also induce the expression of several transcription coregulators of PR, 
including FOXO1, STAT5, and C/EBPβ, and disrupt the binding of the receptor to 
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specific corepressors, such as NCoR and SMRT (14-18). While all these observations 
indicate that PR activity in HESCs is tightly controlled it does not explain well the 
highly temporal regulation of the decidual process during the cycle. One, as yet 
untested, possibility is that decidual transformation of the endometrial stroma in the 
cycle is dependent on coordinated chromatin modifications that create permissive and 
repressive transcriptional environments enabling large gene networks to respond to 
differentiation signals. 
Numerous DNA and histone modifying enzymes govern the accessibility of 
the transcriptional machinery to chromatin, thus determining if a gene is silenced, 
activated, or poised to respond to a stimulus (19-21). One of the most widely studied 
histone modifiers is enhancer of Zeste homolog 2 (EZH2), which along with the 
embryonic ectoderm development (EED) and the zinc finger protein suppressor of 
zeste 12 homologue (SUZ12), makes up the Polycomb-repressive complex 2 (PRC2). 
Within this repressive complex EZH2 serves as the active enzyme that catalyzes the 
trimethylation of H3 on Lys 27 (H3K27me3) leading to gene silencing (22-24). 
Importantly, aberrant expression of EZH2 occurs in a variety of hormone-dependent 
malignancies, including endometrial, breast and prostate cancers (25-29). 
Furthermore, ovarian hormones reportedly regulate EZH2 expression and activity in a 
variety of cell types (30). These observations prompted us to examine the expression 
of EZH2 in human endometrium and to determine if cycle-dependent changes in 
EZH2 methylation activity plays a role in differentiation of HESCs into specialized 
decidual cells.  
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Materials and Methods 
Primary cell cultureThis study was approved by the Hammersmith and Queen 
Charlotte's & Chelsea Research Ethics Committee (1997/5065). Endometrial samples 
were obtained from pre-menopausal consented women without uterine pathology. 
Written informed consent was obtained from all participating subjects prior tissue 
collection. HESCs were isolated and established cultures were maintained as 
described previously (15). For in vitro decidualization, cultures were treated with 
0.5mM 8-Br-cAMP (Sigma, St Louis, Mo, USA) and 1µM 
medroxyprogesteroneacetate (MPA) (Sigma).   
 
Transient transfection of primary cultures 
Primary HESCS were transfected by calcium phosphate coprecipitation using the 
ProFection Mammalian Transfection kit (Promega, Madison, Wi, USA) according to 
manufacturer’s instructions. For EZH2 gene-silencing HESCS were transiently 
transfected with the following small interfering RNA (siRNA) siCONTROL 
nontargeting (NT) siRNA pool (Dharmacon, Lafayette, Co, USA) and EZH2 
siGENOME SMARTpool siRNA (Dharmacon). For EZH2 overexpression the EZH2 
in pCMV-SPORT6 (Open Biosystems, Huntsville, Al, USA) vector was used.   
 
Western blot analysis 
Whole cell protein extracts were obtained by direct lysis in Laemmli buffer. Proteins 
were resolved by SDS-PAGE, transferred to a PVDF membrane and probed with 
antibodies raised against EZH2 (NCL-L-EZH2; Leica Biosystems, Newcastle upon 
Tyne, UK), EZH1 (ab13665; Abcam, Cambridge, UK), H3K27me3 (07-449; 
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Millipore, Billerica, Ma, USA), H3K27ac (ab4729; Abcam), β-actin (ab-8226; 
Abcam). The proteins were visualized by incubation with  HRP-conjugated secondary 
antibodies (Roche, Wellyn Garden City, UK) and the chemiluminescence detected 
using the ECL+ kit (GE Healthcare, Indianapolis, In, USA). 
 
Real-time quantitative PCR (RT-qPCR) 
RNA was extracted using STAT-60 (AMS Biotech, Abingdon, UK) and following 
manufacturer’s instructions. cDNA was synthesized using the SuperScript First-
Strand Synthesis for RT-PCR (Invitrogen, Carlsbad, CA, USA) with oligo-dT primers 
(Invitrogen) after having treated the extracted RNA with amplification grade DNase I 
(Invitrogen). Quantitative PCR (qPCR) was carried out on BioRad Opticon Monitor 3 
Real-Time PCR System. PCR reactions were set up using SYBR Green JumpStart 
Taq (Sigma), 0.20 µM of each primer, 0.5 µl of template in a 15 µl reaction. The 
following program was run on the thermocycler: 50°C for 2 minutes, 95°C for 10 
minutes followed by 40 cycles of 95°C° for 15 seconds, 60°C for 1 minute and 72°C 
for 30 seconds. Input variance was normalized against the expression of the L19 gene, 
which encodes for a non-regulated universally expressed ribosomal protein.  
 
Confocal microscopy 
HESCS were cultured on 4-well chamber slides and decidualized for 2, 4 and 8 days. 
The cells were fixed with 4% paraformaldehyde (Thermoscientfic, Waltham, MA, 
USA). Subsequently they were permeabilized with 0.5% Triton-X and blocked with 
7.5% normal goat serum and 3% BSA in PBS. The slides were hybridized with the 
primary antibody and then with the secondary one conjugated with Alexa Fluor 594. 
The chambers were mounted in Vectashield with DAPI. Alexa Fluor 594 and DAPI 
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were visualized under a Leica SP5 confocal microscope with a 63× oil-immersion 
objective.  
 
Immunohistochemistry 
Paraffin-embedded, formalin-fixed endometrial tissue sections were placed on 1% 
w/v polylysine coated slides. Immunostaining was performed using Vectastain Elite 
ABC kit (Vector Laboratories, Burlingame, CA, USA), according to manufacturer’s 
instructions. The sections were stained with EZH2 antibody (NCL-L-EZH2; Leica). 
 
Chromatin immunoprecipitation (ChIP) 
HESCS were cultured in 10 cm culture dishes, fixed with 1% formaldehyde and 
incubated for 10 minutes at 37°C. After having stopped the fixation with 125 mM 
glycine the nuclei were isolated by incubating at 4°C for 10 minutes in 1 ml Swelling 
buffer (25 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, and 0.1% Nonidet). The 
cells were then scraped and homogenized with a dounce homogenizer. The samples 
were centrifuged for 3 minutes at 16000g at 4°C and the nuclei, collected in a pellet, 
resuspended in 500 µl SDS lysis buffer (1% SDS, 1% Triton-X100, 0.5% 
deoxycholate, 10 mM EDTA, 500 mM Tris-HCl pH 8.1) and sonicated for 30 minutes 
(with 30 second cycles) at 4°C on high power in a Diagenode Bioruptor sonicator. 
The resulting suspension was centrifuged for 15 minutes at 16000 g at 4°C and the 
supernatant diluted ten times in IP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM 
EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl) and then precleared at 4 °C for 3 
hours with Protein A Dynabeads (Invitrogen).  The chromatin was then complexed 
overnight at 4°C with the antibody bound to Protein A Dynabeads and washed with 
the following buffers: Low Salt Buffer (0.1% SDS, 1% Triton-X100, 2 mM EDTA, 
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20 mM Tris-HCl pH 8.1, 150 mM NaCl), High Salt Buffer (0.1% SDS, 1% Triton-
X100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl), LiCl Buffer (250 mM 
LiCl, 1% Nonidet, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8.1), TE 
buffer (10 mM Tris-HCl pH8, 1 mM EDTA) before eluting the chromatin with 250 µl 
Elution buffer (1% SDS, 100 mM NaHCO3) and incubated at room temperature for 
15 minutes. 200 mM NaCl was added to reverse crosslink the proteins and the DNA. 
After an overnight incubation at 65°C 10 mM EDTA, 40 mM Tris-HCl pH 8 and 40 
µg/ml Protease K (Sigma) was added and the sample incubated for a further hour at 
55°C prior to proceeding with the DNA purification using QIAquick PCR 
Purification Kit (Qiagen, Venlo, Netherlands). All the buffers were supplemented 
with protease inhibitors, 1 mM phenylmethanesulfonylfluoride (PMSF) and 10mM 
sodium butyrate. The following antibodies were used in the ChIP experiments: 
H3K27me3 (07-449; Millipore), H3K27ac (ab4729; Abcam) and as negative control 
the rabbit polyclonal anti-mouse IgG (M7023, Sigma) was used.  
 
ChIP-chip array 
Chromatin was immunoprecipitated with an H3K27me3 specific antibody. ChIP 
DNA was amplified using the WGA2 Kit (Sigma), following manufacturer’s 
instructions. The ChIP-chip assays were performed in triplicate, each representing a 
primary culture from an individual patient. A total of 12 primary cultures were 
assayed. Labeling of ChIP DNA and input, hybridization to NimbleGen Human ChIP-
chip 3x720K RefSeq promoter arrays (Roche), and scanning were performed by 
NimbleGen in their service laboratory. Peak detection and statistical analysis was 
carried out using Partek® Genomic Suite ™ (Partek, St. Louis, MO, USA).  
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Results 
Cycle-dependent expression of EZH2 in human endometrium  
EZH2 expression during the menstrual cycle was examined in 5 proliferative and 5 
secretory endometrial biopsies. Western blot analysis of whole tissue lysates showed a 
marked decrease in the expression of this methyltransferase during the secretory 
phase of the cycle (Fig. 1A & B). To further explore the dynamics of this down-
regulation, we focused on the expression of EZH2 during this phase. RT-qPCR 
analysis on timed endometrial biopsies revealed a 3-fold decrease in EZH2 transcript 
levels with the onset of the mid-secretory phase. This reduction in EZH2 mRNA level 
was then maintained for the remainder of the cycle (Fig. 1C). Tissue sections obtained 
between day 14 and 27 were subjected to immunohistochemistry. As shown in Fig. 
1C, EZH2 immunoreactivity was prominent in the epithelial glandular compartment 
during the early secretory phase. It was also abundantly expressed in stromal cells, 
although the staining was less homogenous. As the cycle progressed, a marked loss of 
EZH2 expression was apparent in epithelial cells, resulting in virtual lack of signal in 
this cellular compartment by the end of the cycle. A similar trend was apparent in the 
stroma, although individual cells strongly expressing EZH2 were still present during 
the late-secretory phase. Taken together, these data suggest that the progression of the 
menstrual cycle results in a gradual but marked loss of EZH2 expression in 
differentiating human endometrium. 
 
Loss of EZH2 expression in decidualizing HESCS 
Elevated intracellular cAMP levels initiate differentiation of HESCS while 
progesterone is essential for the maintenance and enhancement of the decidual 
phenotype (5). As EZH2 expression is downregulated in the stromal compartment of 
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differentiating endometrium we examined if this would be the case upon 
decidualization of primary HESCs in vitro. Primary cultures were stimulated with 8-
Br-cAMP and the progestin MPA for various time-points (Fig. 2A).  Total mRNA and 
protein were extracted from parallel cultures to examine the expression of EZH2. 
Unexpectedly, transcript levels were already 80% lower in cells decidualized for 2 
days and this level of repression was maintained throughout the entire time-course 
(Fig. 2A, top panel). The decline in EZH2 mRNA expression was paralleled at protein 
level, although the reduction was more gradual. Upon 8 days of differentiation, 
expression of this methyltransferase was below the level of detection on Western blot 
analysis (Fig. 2A, bottom panel). The loss of EZH2 upon decidualization of HESCS 
was further confirmed by confocal microscopy (Fig. 2B).  
To provide insights into the mechanism of EZH2 repression, primary cultures 
were treated with 8-Br-cAMP, MPA, alone or a combination, for 48 hours. EZH2 
transcripts decreased modestly upon treatment with 8-Br-cAMP, whereas MPA 
reduced the expression level by approximately 50%. However, a combination 8-Br-
cAMP and MPA yielded an additive effect, resulting in approximately 80% reduction 
in EZH2 mRNA levels (Fig 2C, top panel). Again, the regulation of EZH2 transcripts 
was recapitulated at protein level (Fig 2C, bottom panel). Thus, both the cAMP and 
progesterone signal transduction pathways play a role in EZH2 silencing in 
differentiating HESCS, with progesterone being the dominant signal.   
 
Interplay between acetylation and trimethylation of H3K27  
EZH2 catalyzes trimethylation of H3K27, a histone tail modification associated with 
repressive chromatin and gene silencing (31). To examine if loss of EZH2 impacts on 
global cellular H3K27me3 levels, confocal microscopy as well as Western blot 
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analysis were carried out on undifferentiated HESCS and cultures treated with 8-Br-
cAMP and MPA for various time-points. Unexpectedly, differentiation of HESCs for 
as long as 8 days was not associated with a discernible change in overall methylation 
of H3K27 (Fig. 3A & B). This suggested that other enzymes with histone H3 
methylase activity are likely to be present in decidualizing cells. As shown in Fig 3A 
(right panel), EZH1, a functional homolog of EZH2 (32), is indeed expressed in 
HESCs and, if anything, the abundance of this methyltransferase modestly increases 
upon treatment with 8-Br-cAMP and MPA. 
Next, we examined if loss of EZH2 impacts on the methylation status of 
H3K27 at the transcriptional start site (TSS) of highly induced decidua-specific genes. 
PRL and IGFBP-1 are the most widely studied decidual marker genes and their 
transcriptional regulation has been extensively studied (14,33-36). Notably, PRL in 
the endometrium is transcribed from an alternative promoter upstream of a noncoding 
exon, located approximately 6 kb upstream of the pituitary-specific TSS (33). ChIP 
analysis was carried out using a H3K27me3-specific antibody followed by 
amplification of a 98 bp fragment encompassing the -332 to -270bp regulatory region 
of the decidual-specific PRL TSS, which contains several response elements required 
for cAMP- and progesterone-dependent regulation (12,15,36,37). Time-course 
analysis revealed that HESC differentiation is associated with a gradual but dramatic 
loss of this mark at this locus (Fig. 3B). Loss of H3K27me3 was even more rapid and 
pronounced at the proximal IGFBP1 promoter (-263 to -33bp relatively to the TSS). 
Thus, the marked decline of H3K27me3 at specific loci in the absence of a global 
change in levels suggests that decidualization is associated with a dynamic, albeit 
specific, redistribution of the mark.  
Acetlyation of H3K27 (H3K27ac) antagonizes PRC2-dependent gene 
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silencing. Furthermore, acetylation and trimethylation of H3K27 are mutually 
exclusive as both modifications compete for binding to the same lysine residue (38). 
To determine if complementarity between these marks exists in HESCS, we first 
analyzed global levels of H3K27ac in undifferentiated and decidualizing cells. 
Confocal microscopy revealed an increase in H3K27ac upon decidualization in 
HESCS, apparent after 2 days but even more pronounced after 4 and 8 days of 
differentiation (Fig. 4A). This was further confirmed by Western blot analysis, 
demonstrating a gradual increase in the abundance of this mark in decidualizing 
cultures (Fig. 4B).  To verify if loss of H3K27me3 is accompanied by a gain in 
acetylation at specific loci, ChIP with a H3K27ac-specific antibody followed by 
qPCR amplification of the proximal decidual PRL and IGFBP1 promoters was carried 
out. As shown in Fig. 4C, differentiation of HESCS is indeed associated with rapid 
and marked increase in H3K27ac signal upstream of the TSS of both genes. This was 
especially true for the IGFBP1 promoter, where the abundance of this modification 
increased by several multitudes over time.  
 
EZH2 down-regulation is permissive for decidualization 
Next, we explored the functional consequences of EZH2 downregulation on the 
expression of decidual marker genes. First, we used siRNA to silence EZH2 
expression in primary cultures, which were then left untreated or decidualized with 8-
Br-cAMP and MPA for 2 days. The knockdown was highly effective and reduced 
EZH2 expression below the level of detection on Western blot analysis (Fig. 5A). 
Interestingly, EZH2 silencing was sufficient to decrease H3K27 trimethylation on the 
decidual PRL and IGFBP1 promoters by 60% and 90%, respectively (Fig. 5B). 
Notably, EZH2 knockdown enhanced acetylation of the same residue in H3 at the 
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IGFBP1 but only marginally on PRL promoter (Fig. 5C). Furthermore, knockdown of 
this methyltransferase in undifferentiated cells enhanced the subsequent induction of 
both PRL and IGFBP-1 transcripts in response to 8-Br-cAMP and MPA treatment 
(Fig. 5D). There was also a consistent but very discrete increase in basal expression 
levels of these marker genes upon EZH2 knockdown. To confirm that EZH2 inhibits 
decidualization, primary HESC cultures were transfected with an expression vector 
encoding EZH2 and then differentiated with 8-Br-cAMP and MPA for 2 days. 
Overexpression was confirmed by Western blot analysis (Fig. 5E). RT-qPCR analysis 
of parallel cultures demonstrated that exogenous EZH2 expression reduces the 
induction of IGFBP-1 mRNA and, even more pronounced, of PRL transcripts in 
differentiating HESCs (Fig 5F). Together, the data demonstrate that loss of EZH2 
alone is insufficient to induce a decidual phenotype yet determines the cellular 
responsiveness to differentiation stimuli. 
 
Genome-wide redistribution of H3K27me3 upon decidualization and in response 
to EZH2 knockdown 
Our results indicated that loss of EZH2 expression in decidualizing cells results in 
loss of H3K27me3 signal at specific loci yet overall levels of this repressive histone 
modification seem to be maintained. To determine if decidualization is associated 
with genome-wide redistribution of H3K27 methylation, we carried out ChIP-chip 
arrays on undifferentiated HESCs and cells treated with 8-Br-cAMP and MPA for 8 
days, a time-point at which EZH2 expression is virtually undetectable (Fig. 2A). 
Chromatin from three independent, paired undifferentiated and decidualizing cultures, 
was immunoprecipitated with the H3K27me3 antibody, labeled, and hybridized to a 
Roche NimbleGen Human ChIP-chip 3x720K RefSeq promoter array. We identified a 
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significant change (P < 0.05) in H3K27me3 signal at 3008 genomic regions. Of these, 
there was a reduction in methylation in 75% and enrichment in 25% upon 
differentiation of HESCs into decidual cells. Gene ontology (GO) analysis revealed 
that gain of this repressive modification was strongly enriched at promoters of genes 
involved in transcriptional regulation (enrichment score: 7.5; P < 0.001) whereas loss 
of the mark was prominent at genes implicated in response to stimulus (enrichment 
score: 12.5; P < 0.001) (Fig. 6A). As anticipated, one genomic region characterized 
by reduced levels of trimethylated H3K27 in differentiating HESCs was the IGFBP1 
promoter (Fig. 6B). The decidua-specific PRL promoter, however, was not 
represented on the array.  
To determine if this genome-wide redistribution of H3K27me3 upon 
decidualization of HESCs is caused by the loss of EZH2, we repeated the ChIP-chip 
arrays but this time on chromatin immunoprecipitated from three independent 
undifferentiated primary cultures first transfected with non-targeting or EZH2 siRNA. 
Silencing EZH2 expression was sufficient to significantly alter the abundance of 
H3K27me3 at 2029 distinct genomic regions and a comparable number of loci 
displayed a reduction or enrichment in histone modification (53% and 47%, 
respectively). Furthermore, cross-referencing of the two data sets revealed altered 
H3K27me3 at 567 genomic regions in both decidualizing HESCs and upon EZH2 
knockdown in undifferentiated cultures (Fig. 6C). However, the direction of change 
was discordant in 229 regions (40%). In other words, EZH2 knockdown in 
undifferentiated cells only recapitulated the change in H3K27 methylation at 338 of 
3008 (11%) genomic regions altered upon decidualization. These 388 highly EZH2-
responsive regions were also subjected to GO analysis where loss and gain of the 
H3K27me3 repressive mark was found to occur prominently in the proximity of genes 
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involved in response to stimuli (enrichment score: 28; P < 0.05), and cellular growth 
(enrichment score: 6.8 ; P < 0.05), respectively (Fig. 6D).  
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Discussion 
Like other ligand-activated nuclear receptors, progesterone triggers a conformational 
change in PR, which leads to dissociation of chaperone proteins, receptor 
dimerization, and binding to specific DNA recognition sequences in the promoters of 
target genes (39). However, interaction of the activated PR with DNA is in itself 
insufficient to alter gene expression as nuclear receptors do not possess chromatin 
modifying activities necessary to enable or prevent recruitment of the basal 
transcriptional machinery (40-43). Remodeling of local chromatin depends on 
recruitment of coregulators, broadly divided into coactivators and corepressors, to the 
DNA-bound receptor (40,41). Based on their mechanisms of action, nuclear receptor 
coactivators can be categorized into three major function complexes: (i) the SWI/SNF 
complex, which remodel the local chromatin structure through adenosine 
triphosphate-dependent histone acetylation; (ii) the SRC complex, which contain 
acetyltransferases (e.g. CBP, p300, and the p300/CBP-associated factor) and 
methyltransferases (e.g. CARM1 and PRMT1); and (iii) mediator complex, involved 
in the activation of RNA polymerase II and initiation of transcription. Although the 
mechanism of agonist-bound PR-dependent gene repression is still unclear, it is 
widely assumed to involve interaction with NCoR, SMRT or possibly RIP140, 
corepressors capable of recruiting DNA- and histone-methyltransferases complexes  
(44,45). 
In this model, nuclear receptors like PR are viewed as pioneer factors 
responsible for initiating the process of chromatin remodelling near the TSSs of target 
genes. However, this paradigm is being profoundly challenged by novel techniques 
that allow genome-wide mapping of binding of nuclear receptors to DNA (19,46,47). 
Contrary to expectations, a majority of nuclear binding events do not occur proximal 
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to TSSs of target genes but at large distances from promoters (47-49). Moreover, 
rather than the activated receptor inducing a permissive chromatin environment that 
enables transcription, most activated receptors will bind at preexisting sites that are 
constitutively accessible. For example, the binding pattern of the activated 
glucocorticoid receptor to DNA, and subsequent gene regulation, was recently shown 
to be highly cell-specific and comprehensively predetermined by basal differences 
between cell types in chromatin structure (46). When extrapolated to the cycling 
endometrium, these observations strongly suggest that acquisition of responsiveness 
to differentiation signals must be preceded by, or at least occur in concert with, 
genome-wide remodelling of the chromatin. 
This study provides evidence that loss of EZH2 activity in HESCs contributes 
to the chromatin changes necessary for expression of a decidual phenotype in 
response to differentiation cues. While EZH2 transcript levels fell rapidly in response 
to cAMP and progestin treatment, protein levels declined more gradually. The 
kinetics of this response correlated well with the decline in H3K27me3 at the PRL 
and IGFBP1 promoters and, inversely, with the level of transcriptional activation of 
these marker genes (4,12). Furthermore, a parallel gain in the competing activation 
mark H3K27ac was observed at both promoters upon decidualization of HESCs, 
although the amplitude of this response was more pronounced at the TSS of IGFBP1. 
Interestingly, a recent study reported that different modifications are predictive of the 
expression levels of genes that are either rich or poor in the CpG content of their 
promoters. In particular H3K27ac is strongly associated with activation of high but 
not low CpG content promoters (50). In keeping with this model, acetylation of 
H3K27 upon HESC differentiation was not only more pronounced at the IGFBP1 
promoter, which has 68 CpGs, but EZH2 knockdown was sufficient to enrich the 
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mark. In contrast, the decidua-specific PRL promoter is poor in CpG content and 
enrichment in H3K27ac was strictly dependent on cAMP and MPA stimulation. In a 
previous study, we demonstrated that CBP/p300, coactivators that catalyze acetylation 
of H3K27, are indispensible for PRL expression in differentiating HESCs (51), 
suggesting that recruitment of these histone modifiers to decidual promoters requires 
binding of specific transcriptional complexes induced by cAMP and MPA signaling. 
In other words, while loss of EZH2-dependent methyltransferase activity contributes 
to creating a transcriptionally permissive chromatin environment, these changes alone 
are  insufficient to trigger the expression of decidual marker genes in undifferentiated 
HESCs, or even upon stimulation with only MPA (data not shown). 
Downregulation of EZH2 expression in decidualizing HESCs was not 
paralleled by a decline in global cellular H3K27me3 levels as determined by Western 
blot analysis or confocal imaging. However, our ChIP-chip array study suggested a 
net reduction in chromatin-bound methylated  H3K27 after 8 days of differentiation 
as 3-times more genomic regions were reduced than enriched in this modification. 
Nevertheless, residual H3 methylase activity remained apparent in differentiating 
HESCs, even with EZH2 expression below the level of detection. This residual 
activity is likely accounted for by the continuous expression of EZH1. Like EZH2, 
EZH1 integrates in PCR2, although there is evidence that these complexes differ in 
their repressive roles. EZH1 has relative weak intrinsic histone methyltransferase 
activity and is thought to elicit its role by compacting chromatin through interaction 
with nucleosomes (52). Interestingly, EZH2 expression is widely associated with 
cellular proliferation, whereas EZH1 is reportedly more abundant in non-proliferative 
cells (52).  This general pattern of expression fits well with our observation that EZH2 
but not EZH1 is lost upon differentiation of HESCs. 
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In addition to DNA methylation, over 60 different residues within histone tails 
have been identified as targets for various posttranslational modifications, including 
methylation, acetylation, ubiquitination, phosphorylation and sumoyaltion (21,53). 
Mining of existing gene expression revealed that decidualization of HESCs is 
associated with altered expression of members of several classes of chromatin 
modifying enzymes, including DNA methyltransferases (e.g. DNMT3a and 
DNMT3b), DNA binding proteins (e.g. UFRH1) and histone modifying enzymes (e.g. 
SUV420H1). Similarly, the expression of DNMT1 and MDB2, a methyl-CpG binding 
protein, in human endometrium has been shown to be cycle-dependent (54). Because 
of the interdependency of various chromatin modifications (50,55), it was anticipated 
that EZH2 knockdown in undifferentiated HESCs would at best only partially 
recapitulate the changes in H3K27me3 observed upon decidualization. This was 
indeed the case. Only 11% of the genomic regions altered in H3K27me in response to 
prolonged cAMP and MPA stimulation were modified in a similar manner upon 
EZH2 knockdown in untreated cells. These loci could be viewed as highly-dependent 
on EZH2 for remodeling. Interestingly, GO analysis revealed that those regions that 
gain the transcriptionally repressive H3K27me mark upon decidualization of HESCs 
are enriched for genes associated with growth. Even more strikingly, the same 
analysis of regions that lost the mark, thus acquiring a transcriptionally permissive 
chromatin environment, revealed a preponderance of genes functionally associated 
with responsiveness to stimuli. Thus the result of the ChIP-chip arrays further 
supports the notion that downregulation of EZH2 is a key event that renders 
endometrial cells responsive to differentiation and other environmental cues.  
Taken together our data show that cAMP and progesterone signaling reshapes 
the chromatin landscape of HESCs, which in turn enables regulation of large gene 
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networks that underpin the expression of a decidual phenotype. Extrapolated to the in 
vivo situation, our findings suggest that cycle-dependent changes in chromatin 
structure is a major determinant in the cellular responsiveness to differentiation 
signals and the subsequent acquisition of a decidual phenotype. In light of the crucial 
role of EZH2 in this process, it seems likely that perturbations in this or other 
chromatin remodeling enzymes underpin reproductive failure.  
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 Figure Legends 
 
Figure 1. Cycle-dependent expression of EZH2 in human endometrium. A. 
Protein lysates from proliferative (PE) and secretory (SE) endometrium were 
subjected to Western blot analysis and immunoprobed for EZH2. β-actin served as a 
loading control. Panel on the left shows densitometric analysis of Western blots using 
Image J. B. EZH2 transcript levels in timed endometrial biopsies obtained during the 
early- (ES, n=5), mid- (MS, n=5) and late- (LS, n=5) secretory phase of the cycle 
were determined by RT-qPCR. The data, normalized to L19 mRNA, are expressed in 
arbitrary units (a.u.; mean ± SEM). C. Endometrial tissue sections obtained at 
different phases of the cycle were immunostained for EZH2 (brown). The data shown 
in this figure are representative of 3 or more independent experiments. 
 
Figure 2. EZH2 is down-regulated upon decidualization A. confluent HESC 
cultures were either untreated (day 0) or decidualized with 8-Br-cAMP and MPA for 
the indicated time-points. EZH2 expression at mRNA and protein level was 
determined in parallel cultures by RT-qPCR (upper panel) and Western blot analysis 
(lower panel). The RT-qPCR data show the fold change (± SEM of triplicate 
measurments) in EZH2 transcript levels upon treatment relatively to expression in 
untreated cells. B. EZH2 expression in endometrial stromal cells cultured in the 
presence or absence of 8-Br-cAMP and MPA for 2, 4 and 8 days. The intensity of 
EZH2 (red channel) and DAPI nuclear staining (blue channel) were captured by 
confocal microscopy. C. confluent HESC cultures either untreated or decidualized 
with 8-Br-cAMP (cAMP), MPA, or a combination for 2 days. EZH2 expression at 
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mRNA and protein level was determined in parallel cultures by RT-qPCR (upper 
panel) and Western blot analysis (lower panel). The data show the fold change (± 
SEM of triplicate measurments) in EZH2 transcript levels upon treatment relatively to 
expression in untreated cells.  
 
Figure 3.  H3K27 methylation in undifferentiated and decidualizing HESCs. A. 
Primary HESCs treated with 8-Br-cAMP and MPA for the indicated timepoints were 
fixed in formaldehyde, stained, and subjected to confocal microscopy. The upper 
panel represents H3K27me3 staining (red channel), whereas the lower panel shows 
the corresponding nuclear DAPI staining (blue channel). B. Total protein lysates of 
HESCS treated as above were subjected to Western blot analysis and immunoprobed 
for EZH1 and H3K27me. β-actin was used as a loading control. C. Chromatin 
extracted from HESC first decidualized for 2, 4 or 8 days was immunoprecipitated 
with antibodies against H3K27me3 and IgG. The chromatin, normalized to the input, 
was analyzed by qPCR (ChIP-qPCR) with primers specific for the promoter regions 
of PRL (left panel) and IGFBP1 (right panel). Data are expressed as the fold change 
(± SEM of triplicate measurments) relatively to the abundance of chromatin-bound 
H3K27me3 in untreated cells. The data shown in this figure are representative of 3 
independent experiments. 
 
Figure 4. Dynamic changes in H3K27 acetylation upon decidualization of 
HESCs. A. Endometrial stromal cells were cultured in the presence or absence of 8-
Br-cAMP and MPA for the indicated time-points. The intensity of H3K27ac (green 
channel) and the corresponding DAPI nuclear staining (blue channel) were captured 
by confocal microscopy. B. Whole cell protein lysates of HESCS treated as above 
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were subjected to Western blot analysis using an H3K27ac-specific antibody. β-actin 
served as a loading control. C. ChIP was carried out on HESCs decidualized for the 
indicated time-points using antibodies against H3K27ac and IgG. qPCR was caried 
out on the ChIPed DNA with primers specific for the proximal promoter regions of 
PRL (left panel) and IGFBP1 (right panel) and normalized to the input. Data are 
expressed as the fold change (± SEM of triplicate measurements) relatively to the 
abundance of chromatin-bound H3K27ac in untreated cells. The data shown in this 
figure are representative of 3 independent experiments. 
 
Figure 5. EZH2 downregulation is permissive for the induction of decidual 
marker genes. A. Total cell lysates from primary HESC cultures first transfected 
with either non-targeting (NT) or EZH2 siRNA and then treated with cAMP and 
MPA for 2 days were subjected to Western blot analysis and probed with EZH1-, 
EZH2-, and H3K27me3-specific antibodies. β-actin served as a loading control. B. 
ChIP with H3K27me3 and IgG antibodies was performed on cultures treated as 
above. The percipitated DNA fragments were analyzed by qPCR and normalized to 
the input. The primers used were specific for the proximal promoter regions of 
IGFBP1 (left panel) and PRL (right panel). Data are expressed as the fold change (± 
SEM of triplicate measurments) relatively to the abundance of chromatin-bound 
H3K27me3 in untreated cells. C. ChIP was carried out with H3K27ac-specific 
antibody under the experimental conditions described above. D. PRL and IGFBP-1 
transcript levels were measured by RT-qPCR in HESCs first transfected with either 
non-targeting (NT) or EZH2 siRNA and then treated with cAMP and MPA for 2 days. 
The data show fold-change (± SEM of triplicate measurments) in expression relative 
to untreated cells transfected with NT siRNA. E. Protein lysates extracted from cells 
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first transfected with an empty control vector (pCMV) or a plasmid encoding EZH2 
(pCMV-EZH2) vector and then treated with decidualization stimuli for 2 days were 
subjected to Western blot analysis and immunoprobed for EZH2. β-actin was used as 
a loading control. F. Total RNA from parallel cultures was examined for the 
expression of IGFBP-1 (upper panel) and PRL (lower panel) transcripts by RT-qPCR.  
The data (mean ± SEM) are presented as fold-induction and the results are 
representative of 3 repeat experiments. 
 
Figure 6. Genome-wide redistribution of H3K27me3 in decidualizing HESCs and 
upon EZH2 knockdown in undifferentiated HESCs. A. Venn diagram indicating 
the number of genomic loci significantly  (P < 0.05) altered in H3K27 methylation as 
determined by ChIP-chip analysis of HESCs either decidualized with 8-Br-cAMP and 
MPA for 8 days (left) or upon EZH2 knockdown (right).  B. Example of altered 
H3K27me3 peaks in the genomic region encompasssing the IGFBP1 promoter. The 
blue line represents the peaks in the undifferentiated cells whereas the red line 
indicate the corresponding relative level of H3K27me3 in paired cultures decidualized 
with 8-Br-cAMP and MPA for 8 days.  C. GO analysis of genes in the proximity of 
genomic loci characterized by significant loss (X panel) or gain (X panel) in 
H3K27me3 upon decidualization of HESCs. D. GO enrichment analysis of promoter 
regions altered in H3K27 methylation in response to differentiation as well as siRNA-
mediated EZH2 knockdown in undifferentiated cultures.  
 
 
